UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 67

of 'Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects'

67
TI
Bevacizumab plus irinotecan in recurrent glioblastoma.
AU
Chamberlain MC
SO
J Clin Oncol. 2008;26(6):1012.
 
AD
PMID